Sam Khan
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- COVID-19 and healthcare impacts
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 12
- COVID-19 and healthcare impacts 7
- Colorectal Cancer Treatments and Studies 3
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Ashley Robert Dennison (1 shared paper)Giuseppe Garcea (1 shared paper)Andrew M. Fry (2 shared papers)Richard Bayliss (2 shared papers)Laura O’Regan (2 shared papers)Richard A Hubner (1 shared paper)Karen Brown (3 shared papers)Daniel H. Palmer (1 shared paper)
- Journals
- British Journal of Cancer (3 papers)Cancers (3 papers)Annals of The Royal College of Surgeons of England (1 paper)Clinical Colorectal Cancer (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Sam Khan
23 papers receiving 306 citations
Peers
Comparison fields: 5 of 44
- Infectious Diseases 118
- Oncology 106
- Hepatology 27
- Pulmonary and Respiratory Medicine 32
- Health 7
Countries citing papers authored by Sam Khan
This map shows the geographic impact of Sam Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Khan more than expected).
Fields of papers citing papers by Sam Khan
This network shows the impact of papers produced by Sam Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Khan. The network helps show where Sam Khan may publish in the future.
Co-authors
The 25 scholars most cited alongside Sam Khan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 76 | |
| 2 | 2021 | 35 | |
| 3 | 2022 | 34 | |
| 4 | 2022 | 27 | |
| 5 | 2015 | 16 | |
| 6 | 2021 | 14 | |
| 7 | 2021 | 12 | |
| 8 | 2023 | 12 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 11 | |
| 11 | 2023 | 11 | |
| 12 | 2022 | 8 | |
| 13 | 2024 | 8 | |
| 14 | 2023 | 7 | |
| 15 | 2022 | 6 | |
| 16 | 2022 | 4 | |
| 17 | 2025 | 4 | |
| 18 | 2025 | 3 | |
| 19 | 2025 | 3 | |
| 20 | 2022 | 2 |
About Sam Khan
Sam Khan is a scholar working on Oncology, Infectious Diseases, Molecular Medicine, Pulmonary and Respiratory Medicine and Statistics and Probability, having authored 26 papers that have together received 310 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (7 papers), Lung Cancer Treatments and Mutations (3 papers), COVID-19 Clinical Research Studies (3 papers), Colorectal Cancer Treatments and Studies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Curcumin's Biomedical Applications (2 papers), Statistical Methods in Clinical Trials (2 papers) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Infectious Diseases (118 citations), Oncology (106 citations), Hepatology (27 citations), Pulmonary and Respiratory Medicine (32 citations) and Health (7 citations). Sam Khan has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Ashley Robert Dennison, Giuseppe Garcea, Andrew M. Fry, Richard Bayliss, Laura O’Regan, Richard A Hubner, Karen Brown, Daniel H. Palmer, Tom W. Roques and Paul J. Ross. Their work appears in journals such as British Journal of Cancer, Cancers, Annals of The Royal College of Surgeons of England, Clinical Colorectal Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.